Glenn G. Coleman has been appointed Corporate Executive Vice President and Chief Financial Officer, effective April 6, 20261
Kerry Dailey has been appointed Corporate Senior Vice President and Chief Legal Officer in a newly-created position, effective March 30, 20261
Coleman brings over 30 years of financial and operational management experience in the healthcare sector and most recently served as CFO and Chief Administrative Officer of a $1 billion healthcare services business since 202413
Dailey brings 25 years of legal experience advising multinational life science companies and was previously Vice President of Legal and Assistant Corporate Secretary at Alcon, Inc.13
Dailey will oversee Legal, Compliance, Corporate Communications, Government Relations, Security, and Global ESG functions3
Matthew L. Daniel, the current General Counsel, will support Dailey's transition until July 1, 2026, before stepping down after a 20-year career at Charles River12
Michael G. Knell will continue as Corporate Senior Vice President and Chief Accounting Officer after serving in an interim CFO role since September 20251
Incoming CEO Birgit Girshick commented that these appointments strengthen the leadership team to help the company meet evolving industry needs1
Sources:
1. https://www.businesswire.com/news/home/20260218963156/en/Charles-River-Laboratories-Announces-Executive-Appointments
2. https://www.investing.com/news/company-news/glenn-coleman-and-kerry-dailey-to-join-charles-river-labs-leadership-93CH-4510646
3. https://www.marketscreener.com/news/charles-river-laboratories-international-inc-announces-executive-appointments-ce7e5ddede8af122